Kaken Pharmaceutical to Invest $7 Million in Venture Capital Fund


MT Newswires 2022

All news about KAKEN PHARMACEUTICAL CO., LTD.

Sales 2023 71 500 M
504 M
504 M
Net income 2023 10 800 M
76,1 M
76,1 M
Net Debt 2023

P/E ratio 2023 13,0x
Yield 2023 3,99%
Capitalization 141 B
992 M
992 M
Capi. / Sales 2023 1,97x
Capi. / Sales 2024 2,02x
Nbr of Employees 1 164
Free-Float 68,7%

Chart KAKEN PHARMACEUTICAL CO., LTD.



Duration :


Period :




Kaken Pharmaceutical Co., Ltd. Technical Analysis Chart | MarketScreener

Technical analysis trends KAKEN PHARMACEUTICAL CO., LTD.

Short Term Mid-Term Long Term
Trends Bearish Neutral Neutral




Income Statement Evolution

Sell

Buy

Mean consensus UNDERPERFORM
Number of Analysts 1
Last Close Price 3 760,00 JPY
Average target price 3 200,00 JPY
Spread / Average Target -14,9%


.

Leave a Reply

Your email address will not be published. Required fields are marked *